Alnylam Pharmaceuticals Put Buyers Take Profits During Slide

Sanofi divested its 10% stake in Alnylam Pharm

May 3, 2019 at 1:49 PM
facebook twitter linkedin

Amid an up day in the broader equities market, the shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) are trading 6.4% lower at $77.25, on news Sanofi (SNY) divested its roughly 10% stake in the biopharmaceutical firm. This comes after the two companies concluded a research and options phase of an RNAi therapeutics collaboration that began in 2014.

It's already been a rough week for ALNY stock -- down 11.3% so far -- which has been falling since the company's Wednesday-morning earnings report. The shares are now poised to close below their 120-day moving average for the first time since late February, but could be finding a familiar foothold in the $77-$78 range, site of an early January bull gap that served as a floor in the first quarter.

alny stock daily price chart on may 3

ALNY options traders are in overdrive this afternoon, with 3,000 puts and 2,035 calls on the tape -- five times the average daily volume of 981 contracts, and total volume pacing in the 99th annual percentile. Options bears may be taking profits at the May 90 put. Trade-Alert indicates a number of these puts were bought to open on Monday, April 30, for around $4.65 apiece, and the bid price at this now in-the-money strike was last seen at $12.30.

Elsewhere on Wall Street, short sellers have been ramping up their bearish exposure to the biopharma. Short interest edged up 3.1% in the most recent reporting period to 5.52 million shares. This accounts for a healthy 6.1% of Alnylam Pharm's available float, or 7.7 times the average daily pace of trading.

Analysts, meanwhile, are mostly bullish on the ALNY stock. While 10 of 13 covering brokerages maintain a "buy" or better rating, the average 12-month price target of $125.22 is a roughly 62% premium to current trading levels.


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners